Komboglyze 2.5mg-850mg Tablets * Pharmacy Only: Prescription
Company:
AstraZeneca Pharmaceuticals (Ireland) DACStatus:
No Recent UpdateLegal Category:
Product subject to medical prescription which may be renewed (B)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Product Notice
Discontinued Strength Notice
Supply of Komboglyze 2.5mg-850mg Film-Coated Tablets to the Irish market will be discontinued by September 2024.